News | March 29, 2023
Thalassemics India celebrates 35 years of service in Thalassemia
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The company is addressing these observations
The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
Integration of modern and traditional medicine to facilitate the illness to wellness journey
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
The inspection concluded with no observations
Time to combine innovation, access and technology to deliver positive patient outcomes
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
Subscribe To Our Newsletter & Stay Updated
